Article
Resistin predicts disease severity and survival in patients with pulmonary arterial hypertension.
Respiratory research - 6 Jun 2024
Gao Li, Skinner John, Nath Tanmay, Lin Qing, Griffiths Megan, Damico Rachel L, Pauciulo Michael W, Nichols William C, Hassoun Paul M, Everett Allen D, Johns Roger A
Abstract excerpt
BACKGROUND: Abnormal remodeling of distal pulmonary arteries in patients with pulmonary arterial hypertension (PAH) leads to progressively increased pulmonary vascular resistance, followed by right ventricular hypertrophy and failure. Despite considerable advancements in PAH treatment prognosis remains poor. We aim to evaluate the potential for using the cytokine resistin as a genetic and biological marker for...
Topics
Join the communities discussing this publication.